Science Board to hear final CFSAN review
This article was originally published in The Tan Sheet
Executive SummaryFDA's Science Board Nov. 15 reviews a subcommittee's final report on the Center for Food Safety and Applied Nutrition. Additionally, the board will hear an overview of CFSAN's strategic plan, the ongoing review of the Pharmacovigilance Program at the Center for Drug Evaluation and Research and strategic science plan, FDA said in a Oct. 25 Federal Register notice. Requests to make oral presentations must be submitted by Oct. 30. ..
You may also be interested in...
Johnson & Johnson has achieved exceptional growth in recent years, and a raft of new products is set to sustain it further.
Bayer’s drive to lead a new market opportunity in Europe for histology-independent cancer agents like Vitrakvi has been set back by interim decisions from the UK’s NICE and Germany’s IQWiG, but there is a now a clear pathway to follow.
Performance-based managed entry agreements need to be made more effective, but this can only happen if countries relax their stance on confidentiality and share information on MEAs amongst themselves, says a working paper from the OECD.